Associated Papers
TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy.
Noor H et al.
Cancers, 2021
IDH1/IDH2 but not TP53 mutations predict prognosis in Bulgarian glioblastoma patients.
Stancheva G et al.
Biomed Research International, 2014
Select a paper to view details